301207 logo

Hualan Biological Vaccine Inc. Stock Price

SZSE:301207 Community·CN¥12.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301207 Share Price Performance

CN¥20.19
2.81 (16.17%)
CN¥20.19
2.81 (16.17%)
Price CN¥20.19

301207 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet unattractive dividend payer.

2 Risks
1 Reward

Hualan Biological Vaccine Inc. Key Details

CN¥1.2b

Revenue

CN¥266.9m

Cost of Revenue

CN¥935.6m

Gross Profit

CN¥752.6m

Other Expenses

CN¥182.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 23, 2026
0.31
77.80%
15.21%
0%
View Full Analysis

About 301207

Founded
2005
Employees
748
CEO
Wenjue An
WebsiteView website
www.hualanbacterin.com

Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China. The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine. It also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.

Recent 301207 News & Updates

Recent updates

No updates